Search

everythinglearnresearchcommunity

for

Search:↓

Off-pump heart surgery reduces complications without affecting survival rates compared to on-pump surgery.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

Long COVID patients have more health issues than non-infected people.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Bupropion causes more hair loss than other antidepressants, with paroxetine causing the least.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Frailer men have a higher risk of worsening prostate problems and serious health events needing hospital care.

PRP treatment helps hair growth and reduces hair loss in women, but more research needed.

Higher early lead exposure is linked to delayed puberty in girls.

Vitamin D levels do not affect the risk of developing alopecia areata.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Certain genetic variants in ERN1, TACR3, and SPPL2C are linked to when Alzheimer's disease starts.

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

People with ankylosing spondylitis in Taiwan don't have a higher chance of getting alopecia.

Vaccination and timely treatment reduce the risk of long COVID.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.